Advertisement

Ads Placeholder
Loading...

Jubilant Ingrevia Limited

JUBLINGREA.NS•NSE
Healthcare
Biotechnology
₹579.15
₹6.15(1.07%)
Indian Market opens in 34h 47m

Jubilant Ingrevia Limited (JUBLINGREA.NS) Stock Overview

Explore Jubilant Ingrevia Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap91.5B
P/E Ratio34.46
EPS (TTM)$16.75
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$547.41
3 Months$666.26
1 Year Target$777.73

JUBLINGREA.NS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Jubilant Ingrevia Limited (JUBLINGREA.NS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $777.73.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 34.46 and a market capitalization of 91.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.07%
5-Day Change
-0.80%
1-Month Change
4.18%
3-Month Change
-20.25%
6-Month Change
-13.22%
Year-to-Date (YTD) Change
-18.08%
1-Year Change
-13.91%
3-Year Change
56.46%
5-Year Change
102.32%
All-Time (Max) Change
115.54%

Contact Information

https://jubilantingrevia.com
91 12 0436 1000
1A, Sector 16A, Noida, NaN, 201301

Company Facts

22,830 Employees
IPO DateMar 19, 2021
CountryIN
Actively Trading

Frequently Asked Questions